{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:01Z","timestamp":1787021941777,"version":"build-2736575974"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0118178","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T19:34:41Z","timestamp":1428694481000},"page":"e0118178","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Jordi","family":"Real","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Antonia","family":"Lafarga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolors","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.medcli.2013.01.036","article-title":"Degenerative osteoarthritis, osteoporosis and fractures: Controversies and evidences","volume":"141","author":"A Pages-Castella","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.medcli.2009.10.009","article-title":"Osteoporosis: The crisis of a paradigm","volume":"134","author":"M Vazquez","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"ref3","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. report of a WHO study group","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s001980170099","article-title":"Initiation of osteoporosis treatment after bone mineral density testing","volume":"12","author":"A Pressman","year":"2001","journal-title":"Osteoporos Int"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-13-204","article-title":"FRAX(R) tool, the WHO algorithm to predict osteoporotic fractures: The first analysis of its discriminative and predictive ability in the spanish FRIDEX cohort","volume":"13","author":"R Azagra","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s001980070064","article-title":"Long-term risk of osteoporotic fracture in malmo","volume":"11","author":"JA Kanis","year":"2000","journal-title":"Osteoporos Int"},{"key":"ref7","first-page":"15","article-title":"Variability in the recommendations for the clinical management of osteoporosis","volume":"142","author":"J Sanfelix-Genoves","year":"2014","journal-title":"Med Clin (Barc)"},{"key":"ref8","first-page":"305","article-title":"Management of the patient with a high risk of fracture in clinical practice. results from a survey of 174 spanish rheumatologists (OSTEOPAR project)","volume":"7","author":"E Casado","year":"2011","journal-title":"Reumatol Clin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"JA Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"b4229","DOI":"10.1136\/bmj.b4229","article-title":"Predicting risk of osteoporotic fracture in men and women in england and wales: Prospective derivation and validation of QFractureScores","volume":"339","author":"J Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"key":"ref11","first-page":"104","article-title":"Estimate of the 10-year risk of osteoporotic fractures in the spanish population","volume":"140","author":"Lopez-Valcarcel B Gonzalez","year":"2013","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"ref12","first-page":"CD003376","article-title":"Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"GA Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref13","first-page":"CD004523","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"G Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref14","first-page":"CD001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"GA Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","first-page":"82","article-title":"Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in galicia, spain","volume":"43","author":"MM Guerra-Garcia","year":"2011","journal-title":"Aten Primaria"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00228-012-1337-z","article-title":"Hip fracture rates and bisphosphonate consumption in spain. an ecologic study","volume":"69","author":"LM Arias","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"ref17","unstructured":"\u00c1lvarez Rodr\u00edguez E. Optimizaci\u00f3n del tratamiento con alendronate en osteoporosis [Improvement of treatment with alendronate in osteoporosis]. Universidad Complutense de Madrid. 2009; Available: http:\/\/eprints.ucm.es\/8891\/1\/T30917.pdf<\/ext-link>. Accessed 04 April 2014"},{"key":"ref18","first-page":"527","article-title":"Opportunities for improvement in the management of osteoporosis. time to tackle the essential","volume":"141","author":"G Sanfelix-Gimeno","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","article-title":"Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: Systematic review and meta-analysis","volume":"21","author":"I Imaz","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","article-title":"Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women","volume":"305","author":"LY Park-Wyllie","year":"2011","journal-title":"JAMA"},{"key":"ref21","first-page":"2","article-title":"Observational studies in osteoporosis treatment","volume":"61","author":"S Giannini","year":"2009","journal-title":"Reumatismo"},{"key":"ref22","first-page":"658","article-title":"Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis","volume":"17","author":"A Migliore","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.reuma.2011.06.002","article-title":"Nuevos datos sobre el tratamiento con bifosfonatos: \u00bfSon aconsejables unas vacaciones terape\u00faticas? [New data on bisphosphonate therapy: Is a therapeutic advisable vacation?]","volume":"7","author":"E Casado","year":"2011","journal-title":"Reumatol Clin"},{"key":"ref24","first-page":"43","article-title":"Osteoporosis postmenop\u00e1usica: \u00bfestamos previniendo las fracturas? [Postmenopausal osteoporosis: Are we preventing fractures?]","volume":"14","author":"J Agirrezabala","year":"2006","journal-title":"Infac"},{"key":"ref25","unstructured":"Imaz Iglesia I, Rubio Gonz\u00e1lez B, L\u00f3pez Delgado M, Amate Blanco J, G\u00f3mez Pajuelo P, et al. An\u00e1lisis coste-utilidad de los tratamientos farmacol\u00f3gicos para la prevenci\u00f3n de fracturas en mujeres con osteoporosis en Espa\u00f1a. [cost-utility analysis of the prevention drug treatment of fractures in osteoporosis women in Spain]. Madrid: Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias\u2014Instituto de Salud Carlos III. 2010; Available: http:\/\/gesdoc.isciii.es\/gesdoccontroller?action=download&id=14\/09\/2012-3fdd17b5be<\/ext-link>. Accessed 04 April 2014."},{"key":"ref26","first-page":"617","article-title":"SIDIAP database: Electronic clinical records in primary care as a source of information for epidemiologic research","volume":"138","author":"B Bolibar","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference","volume":"15","author":"H Daniel","year":"2007","journal-title":"Political Analysis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"PC Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-11-94","article-title":"Simulation methods to estimate design power: An overview for applied research","volume":"11","author":"BF Arnold","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"ref30","first-page":"135","article-title":"Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP)","volume":"19","author":"Mdel M Garcia-Gil","year":"2011","journal-title":"Inform Prim Care"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00198-013-2369-7","article-title":"The risk of falls on initiation of antihypertensive drugs in the elderly","volume":"24","author":"DA Butt","year":"2013","journal-title":"Osteoporos Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the fracture intervention trial","volume":"280","author":"SR Cummings","year":"1998","journal-title":"JAMA"},{"key":"ref33","first-page":"317","article-title":"\u00bfEst\u00e1 justificado el gasto en f\u00e1rmacos contra la osteoporosis? [Is it justified spending on drugs for osteoporosis?]","volume":"18","author":"S\u00e1ncheza L Jamart","year":"2011","journal-title":"MC Form Med Contin Aten Prim"},{"key":"ref34","unstructured":"Departament de Salut de la Generalitat de Catalunya. Bifosfonats en dones postmenop\u00e0usiques amb risc baix de fractures [Bisphosphonates in postmenopausal women with low risk fracture]. 2013; Available: http:\/\/www20.gencat.cat<\/ext-link>. Accessed Abril 2014."},{"key":"ref35","unstructured":"Richards M. A report for the secretary of state for health by professor sir mike richards CBE. COI Crown. 2010; Available: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/216249\/dh_117977.pdf<\/ext-link>. Accessed 04 April 2014."},{"key":"ref36","unstructured":"Brotons Munt\u00f3 F, Cerecedo P\u00e9rez MJ, Gonz\u00e1lez Gonz\u00e1lez A, L\u00e1zaro G\u00f3mez MJ, Le\u00f3n V\u00e1zquez F, et al. Grupo de trabajo de la semFYC para el proyecto recomendaciones \u00abNo hacer\u00bb [Working group on recommendations semFYC project "not do"]. e-documentos semFYC. 2014; Available: http:\/\/e-documentossemfyc.es\/recomendacion-para-no-hacer-de-la-sociedad-espanola-de-medicina-de-familia-y-comunitaria\/<\/ext-link>. Accessed 24 Abril 2014."},{"key":"ref37","unstructured":"American Academy of Family Physicians. Fifteen things physicians and patiens should question. ABIM Foundation. 2014; Available: http:\/\/www.choosingwisely.org\/doctor-patient-lists\/american-academy-of-family-physicians\/<\/ext-link>. Accessed 04 February 2014."},{"key":"ref38","unstructured":"Barry P, Aspray T, Briers K, Collins G, Compston J, et al. 'Do not do' recommendations: Osteoporosis: Assessing the risk of fragility fracture: NICE guideline. 2014; Available: http:\/\/www.nice.org.uk\/usingguidance\/donotdorecommendations\/detail.jsp?action=details&dndid=1112<\/ext-link>. Accessed 20 June 2014."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0118178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:25:58Z","timestamp":1540333558000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0118178"}},"subtitle":[],"editor":[{"given":"Alfonso","family":"Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0118178","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}